460 related articles for article (PubMed ID: 23404121)
1. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring.
Ferrari G; Bignami F; Giacomini C; Franchini S; Rama P
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1680-8. PubMed ID: 23404121
[TBL] [Abstract][Full Text] [Related]
2. NK1 receptor antagonists as a new treatment for corneal neovascularization.
Bignami F; Giacomini C; Lorusso A; Aramini A; Rama P; Ferrari G
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6783-94. PubMed ID: 25228541
[TBL] [Abstract][Full Text] [Related]
3. Sustained Subconjunctival Delivery of Infliximab Protects the Cornea and Retina Following Alkali Burn to the Eye.
Zhou C; Robert MC; Kapoulea V; Lei F; Stagner AM; Jakobiec FA; Dohlman CH; Paschalis EI
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):96-105. PubMed ID: 28114570
[TBL] [Abstract][Full Text] [Related]
4. Alkali burn to the eye: protection using TNF-α inhibition.
Cade F; Paschalis EI; Regatieri CV; Vavvas DG; Dana R; Dohlman CH
Cornea; 2014 Apr; 33(4):382-9. PubMed ID: 24488127
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of topical infliximab in a mouse model of experimental dry eye.
Li Z; Choi W; Oh HJ; Yoon KC
Cornea; 2012 Nov; 31 Suppl 1():S25-31. PubMed ID: 23038030
[TBL] [Abstract][Full Text] [Related]
6. Effect of metalloproteinase inhibitor on corneal cytokine expression after alkali injury.
Sotozono C; He J; Tei M; Honma Y; Kinoshita S
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2430-4. PubMed ID: 10476814
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment.
Bignami F; Lorusso A; Rama P; Ferrari G
Acta Ophthalmol; 2017 Nov; 95(7):e641-e648. PubMed ID: 28205389
[TBL] [Abstract][Full Text] [Related]
8. Bovine lactoferrin promotes corneal wound healing and suppresses IL-1 expression in alkali wounded mouse cornea.
Pattamatta U; Willcox M; Stapleton F; Garrett Q
Curr Eye Res; 2013 Nov; 38(11):1110-7. PubMed ID: 23898919
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
Kim JW; Jeong H; Yang MS; Lim CW; Kim B
Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
[TBL] [Abstract][Full Text] [Related]
10. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Zhu L; Zhang C; Chuck RS
Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice.
Saika S; Miyamoto T; Yamanaka O; Kato T; Ohnishi Y; Flanders KC; Ikeda K; Nakajima Y; Kao WW; Sato M; Muragaki Y; Ooshima A
Am J Pathol; 2005 May; 166(5):1393-403. PubMed ID: 15855640
[TBL] [Abstract][Full Text] [Related]
12. The Wound Healing Effects of Adiponectin Eye Drops after Corneal Alkali Burn.
Li Z; Cui L; Yang JM; Lee HS; Choi JS; Woo JM; Lim SK; Yoon KC
Curr Eye Res; 2016 Nov; 41(11):1424-1432. PubMed ID: 27159062
[TBL] [Abstract][Full Text] [Related]
13. Use of topical human amniotic fluid in the treatment of acute ocular alkali injuries in mice.
Herretes S; Suwan-Apichon O; Pirouzmanesh A; Reyes JM; Broman AT; Cano M; Gehlbach PL; Gurewitsch ED; Duh EJ; Behrens A
Am J Ophthalmol; 2006 Aug; 142(2):271-8. PubMed ID: 16876508
[TBL] [Abstract][Full Text] [Related]
14. Impact of β-1,3-glucan isolated from Euglena gracilis on corneal epithelial cell migration and on wound healing in a rat alkali burn model.
Choi JA; Oh TH; Choi JS; Chang DJ; Joo CK
Curr Eye Res; 2013 Dec; 38(12):1207-13. PubMed ID: 23841526
[TBL] [Abstract][Full Text] [Related]
15. Safety profile of topical VEGF neutralization at the cornea.
Bock F; Onderka J; Rummelt C; Dietrich T; Bachmann B; Kruse FE; Schlötzer-Schrehardt U; Cursiefen C
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2095-102. PubMed ID: 19151400
[TBL] [Abstract][Full Text] [Related]
16. Alkali burn versus suture-induced corneal neovascularization in C57BL/6 mice: an overview of two common animal models of corneal neovascularization.
Giacomini C; Ferrari G; Bignami F; Rama P
Exp Eye Res; 2014 Apr; 121():1-4. PubMed ID: 24560796
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
18. Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation.
Shin YJ; Hyon JY; Choi WS; Yi K; Chung ES; Chung TY; Wee WR
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4452-8. PubMed ID: 23716625
[TBL] [Abstract][Full Text] [Related]
19. Effects of umbilical cord serum eye drops in a mouse model of ocular chemical burn.
Oh HJ; Jang JY; Li Z; Park SH; Yoon KC
Curr Eye Res; 2012 Dec; 37(12):1084-90. PubMed ID: 23025713
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathological outcomes of subconjunctival triamcinolone injection for the treatment of acute ocular alkali burn in rabbits.
Saud EE; Moraes HV; Marculino LG; Gomes JA; Allodi S; Miguel NC
Cornea; 2012 Feb; 31(2):181-7. PubMed ID: 22081154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
